SusChEM: Novel 1,2-Propanediol Biosynthesis from Renewable Feedstocks through Enzyme Discovery
SusChEM: Novel 1,2-Propanediol Biosynthesis from Renewable Feedstocks through Enzyme Discovery
批准号:
1438332
负责人:
Wei Niu
金额:
$31.76万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2018-07-31
中文摘要
SusChEM:通过酶的发现从可再生原料中生物合成1,2-丙烷经过多年的实践,化学工业面临着可持续发展的挑战,这些挑战来自于来自化石燃料的原料和中间体的潜在减少,以及与其生产相关的日益不受欢迎的环境成本。 基于酶促转化或微生物全细胞合成的生物催化合成越来越多地被探索作为化学生产的替代平台。微生物合成相对于化学合成的关键优势包括反应选择性、分子多样性和减少的环境影响,以及利用可再生原料,如植物基纤维素材料,而不是烃。微生物合成的成功实施本质上解决了化学工业目前面临的可持续性挑战。由于天然途径通常不适合于大规模化学生产,并且不会导致期望的化学产品,因此需要努力发现和开发用于工业化学品的新型生物合成途径。 内布拉斯加大学林肯分校的牛伟教授和郭建涛教授提议通过开发一种新的生物合成路线来实现工业大宗化学品1,2-丙二醇(1,2-PDO)的可持续生产。 1,2 PDO可以整合到其他化学品的生产中,如正丙醇和丙烯。 这项研究结合了科学研究的发现和工程方面。 参加这项工作的UN-L学生将获得关于整合基础科学和工程的重要方面和协同效应的观点。 多学科研究活动将用于支持积极招募代表性不足的本科生和研究生在STEM领域从事研究和职业。拟议工作的科学目标是建立1,2-丙二醇的从头生物合成,一种工业大宗化学品和天然产品,通过减少一种常见的发酵产物乳酸,从可再生原料。 两种已知的1,2-PDO生物合成途径的应用受到起始材料稀缺或涉及细胞毒性生物合成中间体的限制。 PI试图通过使用两种平行方法建立新的1,2-PDO途径来克服这些限制。 第一个是一个发现驱动的方法,重点是确定遗传和催化元素,功能在知之甚少的乳酸还原途径在布氏乳杆菌,产生1,2-PDO缺氧生长条件下。 第二个是设计和工程驱动的方法,重点是开发一种新的人工1,2-PDO生物合成途径,该途径需要将乳酸活化为乳酰辅酶A,然后进行两个连续的还原步骤以形成1,2-PDO。该途径还将使得能够立体特异性生物合成R-和S-1,2-PDO立体异构体。Niu和Guo将应用蛋白质工程来提高瓶颈酶CoA依赖性醛脱氢酶的催化效率。 为了促进合理的诱变,将努力获得蛋白质的晶体结构,其家族在可用的蛋白质结构数据库中代表性不足。 此外,拟议的工作将建立一个新的生长耦合选择方案,允许快速采样的大量酶突变体。 选择方案有可能适用于具有类似辅因子要求的其他酶的定向进化。
英文摘要
SusChEM: Novel 1,2-Propanediol Biosynthesis from Renewable Feedstocks Through Enzyme DiscoveryAfter many years of practice, the chemical industry faces sustainability challenges that arise from both the potentially dwindling feedstocks and intermediates that are derived from fossil fuels, and from the increasingly undesirable environmental costs associated with their production. Biocatalytic syntheses, based on enzymatic conversion or microbial whole-cell synthesis, are increasingly explored as the alternate platform of chemical production. Key advantages of microbial synthesis over chemical syntheses include reaction selectivity, molecular diversity, and reduced environmental impact, and the utilization of renewable feedstocks, such as plant-based cellulosic material, instead of hydrocarbons. The successful implementation of microbial syntheses inherently addresses the sustainability challenges currently facing the chemical industry. Because natural pathways are often not suitable for large-scale chemical production, and do not lead to desired chemical products, efforts are needed into the discovery and the development of novel biosynthetic pathways for industrial chemicals. Professors Wei Niu and Jiantao Guo at the University of Nebraska-Lincoln propose to achieve sustainable production of an industrial bulk chemical, 1,2-propanediol (1,2-PDO), by developing a new biosynthetic route. 1,2 PDO may be integrated into the production of other chemicals, such as n-propanol and propylene. This study combines both the discovery and the engineering aspects of scientific research. UN-L Students participating in this work will gain perspectives on the important aspects and synergistic effects of integrating basic science and engineering. The multidisciplinary research activities will be used to support active recruitment of underrepresented undergraduate and graduate students to pursue studies and careers in STEM areas.The scientific goal of the proposed work is to establish the de novo biosynthesis of 1,2-propanediol, an industrial bulk chemical and a natural product, from renewable feedstocks through the reduction of a common fermentation product, lactic acid. Application of the two known 1,2-PDO biosynthetic routes is limited either by the scarce availability of the starting material or the involvement of cytotoxic biosynthetic intermediate. The PIs seek to overcome these limitations by establishing novel 1,2-PDO pathways using two parallel approaches. The first one is a discovery-driven approach that focuses on identifying the genetic and catalytic elements that function in the poorly understood lactic acid reduction pathway in Lactobacillus buchneri, which produces 1,2-PDO under anoxic growth conditions. The second one is a design and engineering-driven approach that focuses on the development of a novel artificial 1,2-PDO biosynthetic pathway, which entails the activation of lactic acid as lactoyl-CoA followed by two sequential reduction steps to form 1,2-PDO. This pathway would also enable the stereospecific biosynthesis of R- and S-1,2-PDO stereoisomers. Niu and Guo will apply protein engineering to improve the catalytic efficiency of the bottleneck enzyme, the CoA-dependent aldehyde dehydrogenase. To facilitate rational mutagenesis, efforts will be directed to obtain the crystal structure of the protein, of which the family is underrepresented in available protein structure database. In addition, the proposed work will establish a novel growth-coupled selection scheme to allow rapid sampling of large number of enzyme mutants. The selection scheme has the potential to be adapted for directed evolution of other enzymes that have similar cofactor requirement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative Research: OAC Core: CropDL - Scheduling and Checkpoint/Restart Support for Deep Learning Applications on HPC Clusters
-
批准号:2403090
-
项目类别:Standard Grant
-
资助金额:$15.0万
-
财政年份:2024
-
负责人:Wei Niu
-
依托单位:
Engineering Carboxylic Acid Reductase for the Biosyntheses of Industrial Chemicals
-
批准号:1805528
-
项目类别:Standard Grant
-
资助金额:$33.55万
-
财政年份:2018
-
负责人:Wei Niu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: